Kom op tegen Kanker - Call for clinical studies 2025

Research

Funding organisation:

Kom op tegen Kanker vzw

What?

Kom op tegen Kanker has launched the call for clinical studies 2025.

To be eligible for funding, the project must meet the following criteria:

1. It must be a prospective clinical study (interventional or registry-based) investigating patient-relevant outcomes, either focused on the treatment of cancer or focused on the side effect(s) of cancer/ cancer treatment. It may involve a (new) therapy, surgical technique, diagnostic test, lifestyle intervention or a comparison of different treatments (not limited to these examples).
2. The study must be qualitative in terms of evidence,  Research competence, Methodology (including study design and statistical plan) and feasibility.
3. The study must be conducted at any time as a function of maximising added value for (former) patients. In this regard, the study must be characterised by the following aspects:
• Primary outcomes must meet a concrete need of (former) patients and be based on direct input from (former) patients.
• Primary outcomes must be patient-relevant and therefore result in a demonstrable improvement in quality of life and/or a demonstrable improvement in life expectancy while maintaining quality of life.
• A multidisciplinary approach with sufficient attention to the physical, psychological and social functioning of (former) patients.
• The safety of (former) patients must be a priority at all times.
• The accessibility and affordability of medical intervention must be taken into consideration.
4. At every point in the study, (former) patients must be central and active patient participation must be an integral part of the study. Co-creation between (former) patients and researchers is the goal.
5. We strongly encourage collaboration, including at the international level, with academic and non-academic centres to increase feasibility of the study (recruitment) and support for valorisation and implementation, among other things.
6. Research results must be fully valorised and/or implemented to realise the maximum added value for cancer patients in practice as soon as possible.

Kom op tegen Kanker emphasises the complementary nature of its funding. We only award grants for clinical cancer research with a potentially high patient benefit but for which no or insufficient funding is being made available by government, industry and/or other funders.

Applications for funding cannot be made for translational research within the call for clinical research projects.

Project duration: maximum 6 years

Who?

Funding can be applied for by Belgian research institutions (non-profit) for both coordination of and participation in national and international clinical studies. To be eligible, recruitment of patients of Flemish institutions and accessibility of study-based treatment for patients in Flanders must be guaranteed.

Clinical research in the context of a public-private partnership may be eligible if it is necessary for the execution of the project, appropriate agreements regarding intellectual property are in place and if guarantees can be given on accessibility and fair price setting after the research is completed. Commercial/industrial parties cannot apply for funding themselves under any circumstances.
  

Application?

Applications are made via the website using standard application forms made available on the Kom op tegen Kanker website: http://expro.komoptegenkanker.be.

The evaluation of submitted project applications will take place in two stages. In the first phase, an abstract is submitted with a brief description of the project according to the standard forms offered (deadline 17 January 2025, by noon). This abstract is evaluated by both the biomedical expert committee and the biomedical patient committee.

If the abstract is evaluated positively, an extended project proposal may be submitted (submission deadline 14 July 2025, by noon).

More information?

You can find the necessary documents on https://expro.komoptegenkanker.be/.

More information about the regulations and guidelines you can find on the Kom op tegen Kanker website.
  

Deadline

17.01.2025

Contact Hasselt University?

E-mail sarah.szyr@uhasselt.be

Tel. +3211269052